Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy (vol 36, pg 1289, 2011)

被引：0
|
作者：
Friedman, Joseph I.
Lindenmayer, Jean-Pierre
Alcantara, Frances
Bowler, Stephanie
Parak, Mohan
White, Leonard
Iskander, Adel
Parrella, Michael
Adler, David N.
Tsopelas, Nicholas D.
Tsai, Wei-Yann
Novakovick, Vladan
Harvey, Philip D.
Davis, Kenneth L.
机构：
来源：
NEUROPSYCHOPHARMACOLOGY | 2011年 / 36卷 / 10期
关键词：
D O I：
10.1038/npp.2011.68
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Correction to: Neuropsychopharmacology advance online publication, 23 February 2011; doi:10.1038/npp.2011.14 In this article, the name of the twelfth author is incorrect; the correct name is Vladan Novakovic.
引用
收藏
页码：2150 / 2150
页数：1
相关论文
共 9 条
  • [1] Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy (vol 36, pg 1289, 2011)
    Friedman, Joseph I.
    Lindenmayer, Jean-Pierre
    Alcantara, Frances
    Bowler, Stephanie
    Parak, Mohan
    White, Leonard
    Iskander, Adel
    Parrella, Michael
    Adler, David N.
    Tsopelas, Nicholas D.
    Tsai, Wei-Yann
    Novakovick, Vladan
    Harvey, Philip D.
    Davis, Kenneth L.
    Kaushik, Saurabh
    [J]. NEUROPSYCHOPHARMACOLOGY, 2011, 36 (06) : 1317 - 1317
  • [2] Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy
    Joseph I Friedman
    Jean-Pierre Lindenmayer
    Frances Alcantara
    Stephanie Bowler
    Mohan Parak
    Leonard White
    Adel Iskander
    Michael Parrella
    David N Adler
    Nicholas D Tsopelas
    Wei-Yann Tsai
    Vladan Novakovick
    Philip D Harvey
    Kenneth L Davis
    [J]. Neuropsychopharmacology, 2011, 36 : 1289 - 1295
  • [3] Erratum: Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy
    Joseph I Friedman
    Jean-Pierre Lindenmayer
    Frances Alcantara
    Stephanie Bowler
    Mohan Parak
    Leonard White
    Adel Iskander
    Michael Parrella
    David N Adler
    Nicholas D Tsopelas
    Wei-Yann Tsai
    Vladan Novakovick
    Philip D Harvey
    Kenneth L Davis
    [J]. Neuropsychopharmacology, 2011, 36 : 2150 - 2150
  • [4] The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder
    Ristic, Dragana Ignjatovic
    Cohen, Dan
    Obradovic, Andrea
    Nikic-Duricic, Katarina
    Draskovic, Marija
    Hinic, Darko
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2018, 72 (02) : 124 - 129
  • [5] Amisulpride Augmentation of Clozapine in Clozapine-Resistant Schizophrenia: A Case Series (vol 75, pg 234, 2022)
    Poonia, S.
    Sharaf, M.
    Procyshyn, R. M.
    White, R.
    Rafizadeh, R.
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2022, 75 (04): : 346 - 346
  • [6] Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder (vol 159, pg 255, 2002)
    Volavka
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (12): : 2132 - 2132
  • [7] A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia (vol 36, pg 659, 2022)
    Correll, C. U.
    Agid, Ofer
    Crespo-Facorro, Benedicto
    de Bartolomeis, Andrea
    Fagiolini, Andrea
    Seppala, Niko
    Howes, Oliver D.
    [J]. CNS DRUGS, 2022, 36 (09) : 1015 - 1015
  • [8] The Importance of Conduct Disorder in the Treatment of Violence in Schizophrenia: Efficacy of Clozapine Compared With Olanzapine and Haloperidol (vol 178, pg 266, 2021)
    Krakowski, Menahem
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (07): : 671 - 671
  • [9] Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder (vol 161, pg 1837, 2004)
    Simpson
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03): : 644 - 644
1